Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2014 Jul;109(7):950-66; quiz 967.
doi: 10.1038/ajg.2014.131. Epub 2014 Jun 17.

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury

Naga P Chalasani  1 , Paul H Hayashi  2 , Herbert L Bonkovsky  3 , Victor J Navarro  4 , William M Lee  5 , Robert J Fontana  6 ; Practice Parameters Committee of the American College of Gastroenterology
Affiliations
Practice Guideline

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury

Naga P Chalasani et al. Am J Gastroenterol. 2014 Jul.

Abstract

Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. DILI is a diagnosis of exclusion and thus careful history taking and thorough work-up for competing etiologies are essential for its timely diagnosis. In this ACG Clinical Guideline, the authors present an evidence-based approach to diagnosis and management of DILI with special emphasis on DILI due to herbal and dietary supplements and DILI occurring in individuals with underlying liver disease.

PubMed Disclaimer

Comment in

  • Response to Levy.
    Navarro V, Chalasani NP. Navarro V, et al. Am J Gastroenterol. 2015 Mar;110(3):471-2. doi: 10.1038/ajg.2015.14. Am J Gastroenterol. 2015. PMID: 25743713 No abstract available.
  • Response to Chalassani et al.
    Levy R. Levy R. Am J Gastroenterol. 2015 Mar;110(3):471. doi: 10.1038/ajg.2014.426. Am J Gastroenterol. 2015. PMID: 25743714 No abstract available.

Publication types

MeSH terms

Substances